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Src family kinases (SFKs) are non-receptor tyrosine kinases that have been implicated as
regulators of the inflammatory response. In this study, the role of SFK activation in the
inflammatory response of macrophages to encephalomyocarditis virus (EMCV) infection was
examined. Virus infection of macrophages stimulates the expression of cyclooxygenase-2 (COX-
2), interleukin (IL)-1b and inducible nitric oxide synthase (iNOS). Inhibition of SFK attenuates
EMCV-induced COX-2 expression and prostaglandin E2 production, iNOS expression and
subsequent nitric oxide production, and IL-1b expression. EMCV-induced COX-2 expression
requires the activation of nuclear factor-kB and the mitogen-activated protein kinase p38.
Consistent with these previous findings, inhibition of SFKs attenuated the phosphorylation of p38
in response to EMCV infection, suggesting that SFKs may act upstream of p38. These findings
provide evidence that SFK activation plays an active role in the regulation of inflammatory gene
expression by virus-infected macrophages.
INTRODUCTION
Macrophages play a crucial role in the inflammatory
response to pathogens by producing inflammatory medi-
ators, which recruit and activate a variety of cell types. The
immune response of macrophages to pathogens is initiated
bythe recognitionofpathogen-associated molecularpatterns
by pattern-recognition receptors (PRRs) (Medzhitov, 2007).
Activation of these immune receptors initiates signalling
pathways, resulting in the expression of inflammatory genes.
Src family kinases (SFKs) have been implicated in the
regulation of the macrophage inflammatory response to
various stimuli recognized by PRRs (Boulet et al., 1992;
English et al., 1997; Leu et al., 2006; Orliceket al., 1999; Stovall
et al., 2004; Ziegler et al., 1988). SFKs are non-receptor
tyrosine kinases important in the regulation of a variety of
cellular processes including cell proliferation, survival and the
inflammatory response (Lowell, 2004; Okutani et al., 2006;
Parsons & Parsons, 2004). Pharmacological inhibition of
SFKs attenuates cyclooxygenase-2 (COX-2) expression and
nitrite production by rat peritoneal macrophages in response
to lipopolysaccharide, a ligand for the PRR Toll-like receptor
4( T L R 4 )( L e uet al., 2006). Furthermore, SFK inhibition
attenuates tumour necrosis factor (TNF) production and
inducible nitric oxide synthase (iNOS) expression by
RAW264.7 murine macrophages in response to treatment
with bacterial DNA mimetic CpG, a ligand for TLR9 (Stovall
et al., 2004). Whilst SFK activation appears to participate in
the inflammatory gene response to a number of TLRs, little is
known concerning the role of SFKs in regulating virus-
induced inflammatory responses of infected macrophages.
Virus infection of macrophages stimulates an inflammatory
response that is characterized by the expression of COX-2,
iNOS and interleukin (IL)-1b. COX-2 catalyses the oxida-
tion of arachidonic acid to prostaglandin H2, which is
subsequently isomerized to various prostanoids, including
prostaglandin E2 (PGE2) (Smith et al., 2000). PGE2
participates in the inflammatory response by enhancing
the replication of many viruses, whilst inhibiting replication
of other viruses (Steer & Corbett, 2003). The expression of
iNOS and subsequent production of nitric oxide attenuates
virusreplication,inpart,by nitrosylationandinactivationof
viral proteins required for replication (Karupiah et al., 1993;
Saura et al., 1999). IL-1b participates in the inflammatory
response through recruitment of immune cells and has been
implicated in the pathophysiology of many inflammatory
diseases (Arend et al., 2008).
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macrophage response to virus infection, recent studies have
shown that SFK inhibition in dendritic cells results in
attenuation of antiviral signalling in response to dsRNA, a
viral replication intermediate (Johnsen et al., 2006).
Additionally, SFKs have been implicated in the regulation
of TNF-a production in response to human immunodefi-
ciency virus type 1 envelope protein in human macro-
phages (Tomkowicz et al., 2006). In response to
encephalomyocarditis virus (EMCV), Yoon and co-work-
ers showed that intraperitoneal administration of the SFK
inhibitor PP2 attenuated the accumulation of inflamma-
tory cytokine mRNA in peritoneal macrophages (Choi
et al., 2001). These studies suggest a potential role for SFKs
in antiviral signalling in macrophages.
In this study, we examined the role of SFKs in the
regulation of COX-2 production by macrophages in
response to EMCV, a picornavirus that has been used as
a prototype virus to study antiviral responses (Iordanov
et al., 2000). Inhibition of SFKs attenuates EMCV-induced
COX-2 expression and PGE2 production, iNOS expression
and subsequent nitric oxide production, and IL-1b
expression. We have shown previously that p38 activation
is required for poly(I:C)- and EMCV-stimulated COX-2
expression, and we now provide evidence that SFKs may
function upstream of mitogen-activated protein kinase
(MAPK) p38 in the regulation of COX-2 expression. Our
findings suggest a novel role of SFKs in the regulation
of the inflammatory response of macrophages to virus
infection.
RESULTS
SFK inhibition attenuates EMCV-induced COX-2
expression and PGE2 production by macrophages
To examine whether SFKs participate in EMCV-induced
COX-2 protein expression (Steer et al., 2003), RAW264.7
cells were treated with EMCV for 24 h in the absence or
presence of the SFK inhibitor PP2. As shown in Fig. 1(a),
pre-treatment with 10 mM PP2 resulted in ~90% inhibi-
tion of EMCV-induced COX-2 protein expression (deter-
mined by densitometry). PP3, an inactive analogue of PP2,
did not modify EMCV-stimulated COX-2 expression by
RAW 264.7 cells (Fig. 1a). SU6656 is a structurally distinct
SFK inhibitor that also attenuated EMCV-induced COX-2
expression (Fig. 1b), providing evidence that two struc-
turally different SFK inhibitors attenuate the stimulatory
actions of EMCV on COX-2 expression. PP2 treatment
also attenuated EMCV-induced COX-2 protein expres-
sion in primary mouse peritoneal macrophages (~80%
inhibition; Fig. 1c). The inhibitory actions of PP2 on
COX-2 expression appeared to be mediated by attenuation
of mRNA accumulation. Similar to previous studies,
EMCV stimulated the accumulation of COX-2 mRNA
expression following a 6 h treatment (Steer et al., 2006).
Both PP2 and SU6656 reduced EMCV-stimulated COX-2
mRNA accumulation in RAW264.7 cells in a concentra-
tion-dependent manner (Fig. 1d). COX-2 catalyses the
oxidation of arachidonic acid to prostaglandin H2,
which is subsequently isomerized to various prostanoids,
including PGE2 (Smith et al., 2000). Consistent with the
inhibition of COX-2 mRNA and protein expression, PP2
also attenuated EMCV-stimulated PGE2 production by
RAW264.7 cells. Following a 30 min pre-treatment, PP2
reduced EMCV-induced PGE2 production by ~70%
(Fig. 1e). These findings support a role for SFKs in
regulating the expression of COX-2 in virus-infected
macrophages.
To confirm the pharmacological approaches described in
Fig. 1, molecular approaches were used to examine the role
of SFKs in the regulation of COX-2 expression by
macrophages. RAW264.7 cells were transiently transfected
with a control vector or a vector encoding an inactive Src
mutant that contains a K296R point mutation in the kinase
domain and a Y528F mutation at the phosphorylation site
that provides negative regulation of the kinase. There was
attenuation in the stimulatory effects of EMCV on COX-2
expression in RAW 264.7 cells expressing this dominant-
negative Src mutant compared with cells expressing the
empty vector or control macrophages. EMCV-induced
COX-2 protein accumulation was reduced by ~70% in
RAW264.7 cells expressing dominant-negative Src plasmid
(Fig. 2). These findings, which are consistent with the
inhibitory actions of PP2 on EMCV-stimulated COX-2
expression, provide molecular evidence to support a role
for SFK activation in the expression of COX-2 in EMCV-
infected macrophages.
SFK inhibition attenuates EMCV-induced iNOS
and IL-1b expression by macrophages
In addition to COX-2 expression, the macrophage response
to virus infection also includes the expression of IL-1b and
iNOS (Heitmeier et al., 1998), and each of these
inflammatory genes appears to be regulated by signalling
pathways that are common to each gene product and also
by pathways that are selective for the target gene of interest.
Nuclear factor (NF)-kB is the common signalling pathway
that regulates each of these inflammatory genes, whilst the
calcium-independent phospholipase A2 and cAMP-
response element-binding protein appear to be selective
for iNOS (Maggi et al., 2002), extracellular signal-regulated
kinase (ERK) is selective for IL-1b (Maggi et al., 2003), and
c-Jun N-terminal kinase (JNK) and p38 are selective for
COX-2 expression (Steer et al., 2006). To determine
whether SFKs control the expression of inflammatory
genes in addition to COX-2, the effects of EMCV infection
on iNOS expression, nitric oxide production and IL-1b
expression were examined. EMCV-induced iNOS expres-
sion was attenuated by PP2 in a concentration-dependent
manner with a reduction of ~90% at 10 mM (Fig. 3a).
Consistent with iNOS expression, PP2 inhibited EMCV-
induced nitrite production in a concentration-dependent
Src regulation of virus-stimulated COX-2 expression
http://vir.sgmjournals.org 2279manner (Fig. 3a). Similar results for iNOS expression and
nitrite production were observed using a second Src
inhibitor, SU6656 (not shown). In addition to iNOS, PP2
also attenuated EMCV-induced pro-IL-1b expression in
peritoneal macrophages (~60% reduction with 10 mM
PP2; Fig. 3b). Consistent with the inhibitor studies,
transfection with the dominant-negative Src plasmid
attenuated EMCV-induced pro-IL-1b protein expression
by RAW264.7 cells (not shown). These findings suggested
that SFKs participate in the regulation of other EMCV-
induced inflammatory genes, in addition to COX-2.
EMCV rapidly induces Src phosphorylation in
macrophages
To confirm that EMCV activates SFKs in macrophages,
EMCV-induced Src phosphorylation was examined at
Y416, the autophosphorylation site that is indicative of
activation (Lowell, 2004). As shown in Fig. 4, EMCV
stimulated a rapid fourfold increase in Y416 phosphoryla-
tion of Src at 15 min post-infection, and the PP2 inhibitor
prevented this EMCV-induced phosphorylation of Src.
This rapid activation of Src by EMCV is consistent with the
Fig. 1. SFK inhibition attenuates EMCV-induced COX-2 expression by macrophages. (a, b) RAW264.7 cells (110
5 in 400 ml
DMEM) were pre-treated with the indicated concentrations of PP2, PP3 or SU6656 for 30 min at 37 6C and cultured for an
additional 24 h in the presence of EMCV (m.o.i. 1). COX-2 protein expression was determined by Western blot analysis. (c)
Primary macrophages were isolated by peritoneal lavage, adjusted to a final concentration of 410
5 in 400 ml complete CMRL-
1066 and pre-treated for 30 min at 37 6C with 10 mM PP2 as indicated. Macrophages were subsequently infected with EMCV
(m.o.i. 1) for 24 h, and COX-2 protein expression was determined by Western blot analysis of whole-cell lysates.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control in (a)–(c). (d) RAW264.7 cells (210
5
in 400 ml DMEM) were pre-treated with PP2 or SU6656 for 30 min and infected with EMCV (m.o.i. 1) for 6 h, and total RNA
was isolated. The accumulation of COX-2 mRNA was determined by real-time PCR and normalized to GAPDH mRNA levels.
(e) RAW264.7 cells (210
5 in 400 ml DMEM) were pre-treated with PP2 (10 mM) for 30 min at 37 6C and then cultured for an
additional 24 h in the presence of EMCV (m.o.i. 1). Cell culture supernatants were harvested and PGE2 accumulation was
determined by ELISA. The results are representative of two or three independent experiments (a–c) or the mean±SEM of three
independent experiments (d, e). *, P,0.05 compared with the EMCV-treated condition.
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in macrophages in response to EMCV (Moran et al., 2005).
However, in contrast to the transient activation of MAPK
by EMCV (Moran et al., 2005), Src phosphorylation
remained at an increased level 1 h after EMCV treatment
(not shown). The prolonged increase in Src phosphoryla-
tion for greater than 1 h has been observed previously for
other ligands, including dsRNA (Johnsen et al., 2006) and
granulocyte–macrophage colony-stimulating factor (Suh
et al., 2005).
SFKs are not required for EMCV-induced IkB
degradation
Activation of NF-kB is required for expression of the
inflammatory genes COX-2, IL-1b and iNOS by macro-
phages in response to EMCV infection (Moran et al., 2005;
Steer et al., 2003). As SFKs appear to participate in the
regulation of these inflammatory genes, the potential role
of SFKs in the activation of NF-kB was examined. Using
the degradation of IkBa as an index for NF-kB activation,
we showed that inhibition of SFKs using PP2 did not
attenuate EMCV-induced IkBa degradation (Fig. 5a). We
examined IkBa expression at multiple time points after
EMCV infection, and found no effect of PP2 on the
kinetics of IkB degradation (not shown). These findings
suggest that SFKs do not regulate the inflammatory
response by acting upstream of NF-kB activation.
SFK inhibition attenuates EMCV-induced p38
phosphorylation
In addition to NF-kB, EMCV rapidly activates the MAPK
p38, JNK and ERK. Because p38 and JNK regulate EMCV-
induced COX-2 expression by macrophages (Steer et al.,
2006), we hypothesized that SFKs may regulate COX-2
expression upstream of p38 and JNK. A 15 or 30 min
infection with EMCV induced the phosphorylation of p38,
Fig. 2. Transient transfection with a dominant-negative Src
attenuates EMCV-induced COX-2 expression by macrophages.
RAW264.7 cells (210
6) were electroporated with 2 mg dom-
inant-negative Src plasmid (dnSrc) or a vector control, or were
mock transfected. Transfected cells (410
5 in 400 ml DMEM per
condition) were treated with EMCV (m.o.i. 1) for 24 h. Total cell
lysates were harvested and protein expression was determined by
Western blot analysis. The results are representative of three
independent experiments. GAPDH was used as a loading control.
Fig. 3. SFK inhibition attenuates EMCV-induced iNOS and IL-1b
expression, and nitrite production by macrophages. (a) RAW264.7
cells (210
5 in 400 ml DMEM) were pre-treated with the indicated
concentrations of PP2 for 30 min at 37 6C and cultured for an
additional 24 h in the presence of EMCV (m.o.i. 1). iNOS protein
expression was determined by Western blot analysis, and nitrite
production in the culture supernatant was quantified by a Greiss
assay. (b) Peritoneal macrophages (410
5 in 400 ml complete
CMRL-1066) were pre-treated with 10 mM PP2 for 30 min at
37 6C, cultured for 24 h in the presence of EMCV (m.o.i. 1), and
pro-IL-1b protein expression was determined by Western blot
analysis. Results are representative of three independent experi-
ments or represent the mean±SEM of four independent experi-
ments. *, P,0.05 compared with the EMCV-treated condition.
Fig. 4. EMCV infection of macrophages results in Src tyrosine
kinase phosphorylation. RAW264.7 cells (210
5 in 400 ml
DMEM) were pre-treated with 10 mM PP2 for 30 min at 37 6C
and infected with EMCV (m.o.i. 1) for 15 min. Src phosphorylation
was determined by Western blot analysis using a phospho-
specific (Y416) antibody. Total signal transducer and activator of
transcription 1 (STAT1) expression was determined as a loading
control. The results are representative of three independent
experiments.
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phosphorylation (~70 and ~80% inhibition at 15 and 30 min,
respectively), it failed to attenuate ERK or JNK phosphoryla-
tion (Fig. 5b, c). These findings suggest that SFKs
may regulate COX-2 expression by acting upstream of p38.
DISCUSSION
In this study, the role of SFKs in the inflammatory response
of macrophages to EMCV was examined. We showed that
chemical and molecular inhibition of SFKs attenuated
EMCV-induced inflammatory gene expression by macro-
phages. Inhibition of SFKs attenuated EMCV-induced
COX-2, IL-1b and iNOS expression, as well as PGE2 and
nitrite accumulation by macrophages. SFKs have been
implicated in the regulation of the macrophage inflam-
matory response to various PRR ligands. Our current study
extends the role for SFKs in the macrophage inflammatory
response to include a role in the response to virus infection.
Recent studies have identified a number of pathways
involved in the regulation of inflammatory gene expression
in virus-treated macrophages. NF-kB plays a primary role
in regulating macrophage expression of iNOS, COX-2 and
IL-1b in response to EMCV (Heitmeier et al., 1998; Maggi
et al., 2003; Steer et al., 2003). SFKs have been shown to
participate in cytokine-induced COX-2 expression in
human epithelial cells by activating IkB kinase, resulting
in IkBa degradation and NF-kB activation (Huang et al.,
2003). Although NF-kB signalling is required for EMCV-
induced COX-2, IL-1b and iNOS expression by macro-
phages (Heitmeier et al., 1998; Steer et al., 2003), we
showed that SFK inhibition does not appear to prevent
EMCV-stimulated IkBa degradation. These findings sug-
gest that SFKs do not act upstream of NF-kB. In addition
to NF-kB, the activation of a secondary signalling pathway
that is selective for the target gene of interest is also
required for EMCV-induced inflammatory gene expression
by macrophages. These secondary signalling pathways
include JNK and p38 activation for COX-2 (Steer et al.,
2006), ERK activation for IL-1b (Maggi et al., 2003) and
calcium-independent phospholipase A2 for iNOS (Maggi
et al., 2002). The ability of PP2 to attenuate EMCV-
stimulated p38 activation suggests that SFKs participate in
EMCV-induced COX-2 expression through the activation
of p38. SFK inhibition did not modify EMCV-stimulated
JNK and ERK phosphorylation, suggesting that activation
of these pathways by virus infection occurs by SFK-
independent processes. In accordance with these findings,
SFKs have been shown to act upstream of p38 in the
activation of neutrophils (Mocsai et al., 2000). At present,
it is unclear how SFKs participate in the regulation of
macrophage expression of iNOS and IL-1b in response to
EMCV. Whilst we have previously identified a primary role
for ERK in the regulation of IL-1b expression, and for NF-
kB in the regulation of IL-1b and iNOS expression in
response to EMCV, inhibition of SFKs does not modify
activation of these pathways in response to EMCV
infection, suggesting the participation of pathways in
addition to NF-kB, ERK and SFKs. The proposed
mechanism by which SFKs regulate EMCV-induced
COX-2 expression is depicted in Fig. 6.
Infection of macrophages with EMCV results in the rapid
phosphorylation of Src; however, the mechanisms by which
SFKs are activated have yet to be determined. Whilst the
dsRNA-dependent protein kinase R (PKR) initiates various
antiviral responses in infected cells, a number of studies
have shown that EMCV-stimulated MAPK activation and
inflammatory gene expression do not require the presence
of PKR (Moran et al., 2005; Steer et al., 2003). Recently,
SFKs were shown to participate in antiviral signalling
(interferon regulatory factor-3 activation and STAT1
phosphorylation) in dendritic cells by associating with
TLR3 (Johnsen et al., 2006). However, the inflammatory
Fig. 5. IkBa degradation and MAPK phos-
phorylation. RAW264.7 cells (210
5 in 400 ml
DMEM) were pre-treated with 10 mM PP2 and
then infected with EMCV (m.o.i. 1) for 15 min
(a, c) or for the indicated times (b). IkBa
degradation (a) and MAPK phosphorylation (b,
c) were examined by Western blot analysis.
GAPDH and total STAT1 protein expression
were determined as loading controls. The
results are representative of three independent
experiments.
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activation and COX-2 expression, occurs in the absence of
the dsRNA receptor TLR3 (Steer et al., 2006). Furthermore,
the intracellular dsRNA receptor melanoma differenti-
ation-associated gene 5 (mda5) (Gitlin et al., 2006) does
not appear to mediate the inflammatory response to
EMCV (J. Corbett & B. Christmann, unpublished data).
Thus, EMCV activates inflammatory pathways independ-
ent of PKR, TLR3 and mda5. The signalling receptor
activated by EMCV is currently unknown. The intracellular
dsRNA receptor retinoic acid inducible gene I (RIG-I) may
mediate the EMCV-induced inflammatory response of
macrophages (Yoneyama et al., 2004). However, we believe
that RIG-I is not a likely candidate, because EMCV capsid
void of virus RNA is capable of activating MAPK and NF-
kB pathways and iNOS expression, suggesting that the
signalling pathways regulating inflammatory gene expres-
sion do not require viral RNA accumulation or viral
protein expression (Moran et al., 2005). These findings
suggest that EMCV capsid protein may activate signalling
pathways by interacting with a cell-surface receptor.
Consistent with this possibility, MAPK and NF-kB
signalling pathways, as well as SFKs, are rapidly activated
after a 15 min EMCV infection. SFKs are known to be
activated in response to stimulation of various cell-surface
receptors, including G-protein-coupled receptors (GPCRs)
(Thomas & Brugge, 1997). SFKs can be activated through
the G-protein subunits Gas and Gai (Ma et al., 2000), as
well as independently of G proteins (McGarrigle & Huang,
2007; Sun et al., 2007). We are currently examining the
potential role of GPCRs as regulators of inflammatory gene
expression by virus-infected macrophages.
METHODS
Materials and animals. RAW264.7 cells and L929 cells were
obtained from the Washington University Tissue Culture Support
Center (St Louis, MO, USA). Dulbecco’s modified Eagle’s medium
(DMEM; containing 10% heat-inactivated fetal calf serum and 16 L-
glutamine), CMRL-1066 tissue culture medium, L-glutamine, peni-
cillin and streptomycin were from Gibco-BRL. C57BL/6J mice were
purchased from Harlan. PP2, PP3 and SU6656 were purchased from
Calbiochem. Rabbit anti-COX-2 and anti-iNOS antiserum were
obtained from Cayman Chemicals. 3ZD monoclonal anti-pro-IL-1b
was obtained from the Biological Resources Branch at the NCI
(National Institutes of Health, Bethesda, MD, USA), rabbit anti-
phospho-ERK, anti-phospho-p38 and anti-phospho-JNK from
Promega, rabbit anti-IkBa and rabbit anti-STAT1 antiserum from
Santa Cruz Biotechnology, mouse monoclonal anti-Src (clone GD11)
from Upstate, rabbit anti-phospho-Src (Y416) from Cell Signaling
Technology and mouse anti-GAPDH antiserum from Ambion.
Horseradish peroxidase-conjugated donkey anti-rabbit and donkey
anti-mouse antibodies were obtained from Jackson ImmunoResearch.
The PCR primers for COX-2 and GAPDH were purchased from
Integrated DNA Technologies. The dominant-negative Src in the
pUSEamp expression vector was from Upstate.
Peritoneal macrophage isolation and cell culture. Primary
macrophages were obtained from wild-type C57BL/6J mice by
peritoneal lavage as described previously (Beckerman et al., 1993).
Briefly, the peritoneal cavity was injected with 10 ml ice-cold Hanks’
balanced salt solution, the lavage was extracted and peritoneal exudate
cells were collected by centrifugation, washed and plated at a density
of 4610
5 cells in 400 ml complete CMRL-1066. Peritoneal cells were
washed with CMLR-1066 to remove non-adherent cells.
RAW264.7 cells were removed from growth flasks by treatment with
0.05% trypsin/0.02% EDTA at 37 uC, washed with DMEM and
plated at the indicated concentrations. Macrophages were cultured for
a minimum of 2 h under an atmosphere of 95% air, 5% CO2 prior to
initiation of the experiments.
Virus propagation and infection. The B variant of EMCV was a
generous gift from Dr Ji-Won Yoon (University of Calgary, Alberta,
Canada) and has been described elsewhere (Bae et al., 1989). EMCV
was propagated in L929 cells, supernatants were clarified by
centrifugation and titres were determined by plaque assay. Cell
monolayers were infected at an m.o.i. of 1 by the addition of EMCV
to the culture medium at 37 uC for the times indicated.
Western blot analysis. Protein samples were separated under
denaturing conditions by SDS-PAGE and immobilized on nitrocellu-
lose membranes (GE Healthcare) or PVDF membranes (Pall Life
Sciences) under semi-dry transfer conditions. Antibody dilutions
were as follows: rabbit anti-COX-2, 1:2000; mouse anti-pro-IL-1b,
1:2000; mouse anti-GAPDH, 1:10000; rabbit anti-phospho-p38,
1:4000; rabbit anti-phospho-ERK, 1:5000. All other primary
antibodies were used at 1:1000. Horseradish peroxidase-conjugated
donkey anti-mouse and donkey anti-rabbit secondary antibodies were
used at 1:5000 and 1:7000 dilutions, respectively. Antigen was
detected by chemiluminescence according to the manufacturer’s
specifications (GE Healthcare).
Real-time PCR. Total RNA was isolated from macrophages using an
RNeasy kit according to the manufacturer’s instructions (Qiagen).
First-strand cDNA synthesis was performed using oligo(dT) and a
reverse transcriptase Superscript pre-amplification system
(Invitrogen) following the manufacturer’s recommendations. Real-
time PCR was performed using iQ SYBR Green Supermix (Bio-Rad)
and a Research DNA Engine Opticon II thermocycler with
continuous fluorescence detection (MJ Research). The mRNA levels
of COX-2 were normalized to those of GAPDH. The PCR primer
sequences for COX-2 were: 59-TTTGTTGAGTCATTCACCAGACA-
GAT-39 (forward) and 59-CAGTATTGAGGAGAACAGATGGGATT-
Fig. 6. Proposed mechanism by which SFKs regulate EMCV-
induced COX-2 expression in macrophages.
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elsewhere (Arnush et al., 1998).
Transfection. RAW264.7 cells were transiently transfected using an
Amaxa Nucleofector electroporator (Amaxa Biosystems). The cells
were removed from growth flasks by treatment with 0.05% trypsin/
0.02% EDTA at 37 uC, washed with DMEM and incubated for 2 h at
37 uC. The cells (2610
6) were resuspended in electroporation buffer
and electroporated with 2 mg plasmid using program D-032. A total
of 4610
5 cells in 400 ml DMEM were plated per condition. Six hours
after transfection, the medium was replaced and the cells were
cultured overnight at 37 uC. The cells were washed twice with PBS
before initiation of experiments. We obtained a transfection efficiency
of ~50%, as determined by electroporation with a plasmid expressing
enhanced green fluorescent protein.
Determination of nitrite and PGE2. Nitrite production was
determined by the addition of 50 ml Greiss reagent to 50 ml
macrophage cell culture supernatant (Green et al., 1982).
Absorbance at 540 nm was measured and nitrite concentrations were
quantified by comparison to a sodium nitrite standard curve. PGE2
release in supernatants was determined using a PGE2 enzyme
immunosorbent assay according to the manufacturer’s specifications
(Cayman Chemicals).
Statistics. Statistical comparisons between groups were made using
one-way analysis of variance. Significant differences between groups
(P,0.05) were determined by Newman–Keuls post-hoc analysis.
Western blots were quantified by densitometry using ImageQuant
software (GE Healthcare) and values were normalized to loading
controls.
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